Hemofiltration: determinants of drug loss and concentration.

Ultrafiltration has proven to be an effective method of reducing post-cardiopulmonary bypass edema and the inflammatory response associated with activation of the complement cascade. Recently, a modified ultrafiltration process has been developed which allows further hemoconcentration after weaning from bypass. Both of these procedures can have an effect upon the concentrations of many of the pharmaceutical agents being used either pre- or perioperatively. Based upon work done by other investigators in the field of dialysis, we have developed sieving coefficients for many cardiovascular drugs in order to provide an estimation of their loss during extended periods of hemofiltration. Our study utilized the pharmacological and physical characteristics for volume of distribution and protein binding to determine the movement of drugs through a hemofilter. Our results demonstrated that concentrations of certain drugs used during open heart surgery may be significantly increased or decreased with the use of hemofiltration techniques.

[1]  W. Greeley,et al.  Hemofiltration during Cardiopulmonary Bypass in Pediatric Cardiac Surgery: Effects on Hemostasis, Cytokines, and Complement Components , 1994, Anesthesiology.

[2]  R. Groom,et al.  Alternative method of ultrafiltration after cardiopulmonary bypass. , 1994, The Annals of thoracic surgery.

[3]  J. van der Linden,et al.  Cytokine production and hemofiltration in children undergoing cardiopulmonary bypass. , 1993, The Annals of thoracic surgery.

[4]  M. Elliott,et al.  Ultrafiltration and modified ultrafiltration in pediatric open heart operations. , 1993, The Annals of thoracic surgery.

[5]  B. Risberg,et al.  Hemofiltration modifies complement activation after extracorporeal circulation in infants. , 1993, The Annals of thoracic surgery.

[6]  A. Zydney,et al.  Effect of blood-membrane interactions on solute clearance during hemodialysis. , 1993, ASAIO journal.

[7]  M. Elliott,et al.  Interleukin-8 release and neutrophil degranulation after pediatric cardiopulmonary bypass. , 1993, The Journal of thoracic and cardiovascular surgery.

[8]  T. Golper.  Drug removal during continuous renal replacement therapies , 1993 .

[9]  T. Evans,et al.  Organ dysfunction and cardiopulmonary bypass: the role of complement and complement regulatory proteins. , 1993, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[10]  G M Pacifici,et al.  Methods of Determining Plasma and Tissue Binding of Drugs , 1992, Clinical pharmacokinetics.

[11]  Y. Michotte,et al.  The use of microdialysis for the determination of plasma protein binding of drugs. , 1992, Journal of pharmaceutical and biomedical analysis.

[12]  J. Cazenave,et al.  Minimodule dialyser for quantitative ex vivo evaluation of membrane haemocompatibility in humans: comparison of acrylonitrile copolymer, cuprophan and polysulphone hollow fibres. , 1992, Biomaterials.

[13]  M. Elliott,et al.  A prospective randomized study of a modified technique of ultrafiltration during pediatric open-heart surgery. , 1991, Circulation.

[14]  A. Knight,et al.  A successful modification of ultrafiltration for cardiopulmonary bypass in children , 1991, Perfusion.

[15]  D. Bose,et al.  hemofiltration reverses left ventricular dysfunction during sepsis in dogs. , 1990, Anesthesiology.

[16]  W. Bennett,et al.  Drug Removal by Continuous Arteriovenous Haemofiltration , 1988, Medical toxicology and adverse drug experience.

[17]  A. Kaplan,et al.  Sieving Characteristics of a new Polysulfone Hemofilter for use with Continuous Arterio-venous Hemofiltration , 1987, International Journal of Artificial Organs.

[18]  A. Saad,et al.  Gentamicin and phenytoin sieving through hollow-fiber polysulfone hemofilters. , 1986, Kidney international.

[19]  T. Golper.  Continuous arteriovenous hemofiltration in acute renal failure. , 1985, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[20]  T. Golper,et al.  Drug removal during continuous arteriovenous hemofiltration: theory and clinical observations. , 1985, The International journal of artificial organs.

[21]  W. Bennett,et al.  Removal of therapeutic drugs by continuous arteriovenous hemofiltration. , 1985, Archives of internal medicine.

[22]  D. Magilligan.  Indications for ultrafiltration in the cardiac surgical patient. , 1985, The Journal of thoracic and cardiovascular surgery.

[23]  R. Longnecker,et al.  Continuous arteriovenous hemofiltration. A report of six months' experience. , 1984, Annals of internal medicine.

[24]  C. Oyama,et al.  Ultrafiltration during cardiopulmonary bypass: laboratory evaluation and initial clinical experience. , 1984, The Annals of thoracic surgery.

[25]  M Wolfson,et al.  Drug prescribing in renal failure: dosing guidelines for adults. , 1983, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[26]  S. Nakamoto,et al.  Continuous slow ultrafiltration in oliguric acute renal failure. , 1980, Transactions - American Society for Artificial Internal Organs.

[27]  F. Putnam,et al.  The Plasma Proteins. II , 1961 .